Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/16/2010 | US20100317109 Factor |
12/16/2010 | US20100317108 Cryopreservation of Biological Cells and Tissues |
12/16/2010 | US20100317107 Method and device for collecting and preserving cells for analysis |
12/16/2010 | US20100317106 Harvesting target materials from centrifuged suspensions |
12/16/2010 | US20100317105 Methods and compositions for controlling efficacy of RNA silencing |
12/16/2010 | US20100317104 Cell culture media |
12/16/2010 | US20100317103 Efficient generation of neural progenitors, neurons, and dopaminergic neurons from human embryonic stem cells |
12/16/2010 | US20100317102 Cell Culture Method and Automatic Culture System Using the Method |
12/16/2010 | US20100317101 Culture System for Rapid Expansion of Human Embryonic Stem Cells |
12/16/2010 | US20100317100 Compositions and methods for establishing and maintaining stem cells in an undifferentiated state |
12/16/2010 | US20100317099 Liquid Separation from Adipose Tissue |
12/16/2010 | US20100317098 Compositions and Methods for Diagnosing and Treating Cancer |
12/16/2010 | US20100317096 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
12/16/2010 | US20100317083 Methods and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
12/16/2010 | US20100317080 Method for the treatment of biological tissue of animal or human origin, such as porcine, bovine pericardium or human cadaver heart valves, and biological tissue treated accordingly |
12/16/2010 | US20100317060 Method for highly amplifying target gene in mammalian cell and vector therefor |
12/16/2010 | US20100317055 Recombinant Cell Clones Having Increased Stability and Methods of Making and Using the Same |
12/16/2010 | US20100317054 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF |
12/16/2010 | US20100317049 Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals |
12/16/2010 | US20100317046 Non-Endogenous, Constitutively Activated Versions of Human G Protein Coupled Receptor: FSHR |
12/16/2010 | US20100317036 Mycobacterium Antigens |
12/16/2010 | US20100317025 Diagnostic Method for Celiac Sprue |
12/16/2010 | US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9 |
12/16/2010 | US20100316989 Method for screening an inhibitory agent of hbv proliferation by using the interaction between hbv capsid and surface proteins based on cellular imaging |
12/16/2010 | US20100316988 Method and device for filtering platelets |
12/16/2010 | US20100316723 Compositions and methods for treating inflammation |
12/16/2010 | US20100316715 Chitosan composition |
12/16/2010 | US20100316703 Rna interference mediating small rna molecules |
12/16/2010 | US20100316702 Compositions and methods for regulating erythropoeitin expression and ameliorating anemia and stimulating erythropoiesis |
12/16/2010 | US20100316701 Compositions and method for manipulating pim-1 activity in circulatory system cells |
12/16/2010 | US20100316698 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
12/16/2010 | US20100316697 Methods and compositions for drug targeting |
12/16/2010 | US20100316690 Modular assembly of tissue engineered constructs |
12/16/2010 | US20100316688 Methods for culturing stem and progenitor cells |
12/16/2010 | US20100316679 Compositions for treating or preventing obesity and insulin resistance disorders |
12/16/2010 | US20100316664 Agent For Growing Fibroblasts |
12/16/2010 | US20100316658 Method for producing an antitumoral vaccine based on surface endothelial cell antigens |
12/16/2010 | US20100316649 Small molecule inhibitors of spleen tyrosine kinase (syk) |
12/16/2010 | US20100316645 Bispecific Antigen Binding Proteins |
12/16/2010 | US20100316644 Truncated actriib-fc fusion proteins |
12/16/2010 | US20100316642 Complexes of grp94 with human immunoglobulin g |
12/16/2010 | US20100316634 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
12/16/2010 | US20100316632 Means and methods for enhancing differentiation of haematopoietic progenitor cells |
12/16/2010 | US20100316623 Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria |
12/16/2010 | US20100316622 Diagnosis and treatment of cardiac disorders |
12/16/2010 | US20100316616 Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases |
12/16/2010 | US20100316615 Antisense Oligonucleotides Against VR1 |
12/16/2010 | US20100316613 Feeder cell-free culture medium and system |
12/16/2010 | US20100316612 Primed cell therapy |
12/16/2010 | US20100316610 Mutant having uracil phosphoribosyl transferase activity |
12/16/2010 | US20100316604 Interferon lambda fusion polypeptides |
12/16/2010 | US20100316596 Compositions and methods for treatment of diseases and disorders associated with cytokine signaling |
12/16/2010 | US20100316590 Compositions and methods related to poloxamer copolymer membrane sealant |
12/16/2010 | US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy |
12/16/2010 | US20100316563 Method For The Preparation Of New Oligoclonal Antibodies |
12/16/2010 | CA2772869A1 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells |
12/16/2010 | CA2768246A1 Serine rich peptides having antioxidative stress properties |
12/16/2010 | CA2767164A1 Methods for culturing stem and progenitor cells |
12/16/2010 | CA2765242A1 Process for production of protein |
12/16/2010 | CA2765237A1 Novel protein and gene that codes therefor |
12/16/2010 | CA2764559A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stresstolerance |
12/16/2010 | CA2764446A1 Methods of generating hybrid/chimeric cells, and uses thereof |
12/16/2010 | CA2764377A1 Methods of generating cells exhibiting phenotypic plasticity |
12/16/2010 | CA2764105A1 Growth hormone polypeptides and methods of making and using same |
12/16/2010 | CA2763792A1 Expression cassettes derived from maize |
12/16/2010 | CA2763690A1 Devices for the production of cell clusters of defined cell numbers and cluster sizes |
12/15/2010 | EP2261363A2 Down-regulation of gene expression using artificial mircoRNAa |
12/15/2010 | EP2261359A1 Mannanases |
12/15/2010 | EP2261358A2 Novel streptococcus antigen |
12/15/2010 | EP2261335A1 Compositions and methods for increasing bone mineralisation |
12/15/2010 | EP2261329A2 Subtilases |
12/15/2010 | EP2261325A1 Process for cell cultivation and cryopreservation |
12/15/2010 | EP2261324A1 Process for cell cultivation and cryopreservation |
12/15/2010 | EP2261250A1 Albumin fusion proteins |
12/15/2010 | EP2261249A2 KDR peptides and vaccines comprising the same |
12/15/2010 | EP2261248A2 KDR peptides and vaccines comprising the same |
12/15/2010 | EP2261247A2 KDR peptides and vaccines comprising the same |
12/15/2010 | EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
12/15/2010 | EP2261229A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
12/15/2010 | EP2261228A1 Promoters for regulation of gene expression in plant roots |
12/15/2010 | EP2261227A1 Promoters for regulation of gene expression in plant roots |
12/15/2010 | EP2260861A1 Administration of dendritic cells partially matured in vitro for the treatment of tumors |
12/15/2010 | EP2260854A1 Sperm suspensions for sorting into x or y chromosome-bearing enriched populations |
12/15/2010 | EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens |
12/15/2010 | EP2260801A2 Method for selective disruption of fatty tissue by controlled cooling |
12/15/2010 | EP2260097A1 Disease model incorporation into an artificial immune system (ais) |
12/15/2010 | EP2260096A1 Methods of applying physical stimuli to cells |
12/15/2010 | EP2259802A1 Drug fusions and conjugates |
12/15/2010 | EP2046947B1 Method for the production of multipotent stem cells |
12/15/2010 | EP1841878B1 Method for the generation of virus producing cell lines and cell lines |
12/15/2010 | EP1751661B1 Method for selectively expanding, selecting and enriching stem/progenitor cell populations |
12/15/2010 | EP1725668B1 Genetically modified plants and their applications in phytoremediation. |
12/15/2010 | EP1687417B1 Plants with reduced activity of a class 3 branching enzyme |
12/15/2010 | EP1650293B1 Magnetic cell and method of using the same |
12/15/2010 | EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
12/15/2010 | EP1503985B1 Polypeptides and biosynthetic pathways |
12/15/2010 | EP1123977B1 GENES ENCODING PROTEINS REGULATING pH OF VACUOLES |
12/15/2010 | EP1112077B1 Method for detection of biological factors in epidermis |
12/15/2010 | EP1093515B1 Electrofusion chamber |
12/15/2010 | EP1076703B2 Therapeutic uses of il-17 homologous polypeptides |